Eloxx Pharmaceuticals Inc (NASDAQ:ELOX)
| 4.34 Delayed Data As of Feb 03 |  +0.04 / +0.93%Today’s Change | 1.70 Today|||52-Week Range 24.60 | +138.46% Year-to-Date |
Latest ELOX News | Press Releases
No recent news for Eloxx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.30 |
| Today’s open | 4.07 |
| Day’s range | 4.05 - 4.55 |
| Volume | 1,015 |
| Average volume (3 months) | 86,778 |
| Market cap | $9.0M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -10.68% |
| Earnings growth (this year) | +56.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NEPTNeptune Wellness Sol... | +0.16 | +19.51% |
| BLCMBellicum Pharmaceuti... | 0.00 | 0.00% |
| CWBRCohBar Inc | 0.00 | 0.00% |
| KAKineta Inc | +0.34 | +4.37% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$4.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
